Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
AQST [NASD]
Aquestive Therapeutics, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.58 Insider Own2.90% Shs Outstand35.56M Perf Week-3.85%
Market Cap126.20M Forward P/E- EPS next Y-1.28 Insider Trans-6.31% Shs Float34.48M Perf Month-14.70%
Income-53.90M PEG- EPS next Q-0.44 Inst Own45.60% Short Float6.50% Perf Quarter-10.96%
Sales48.20M P/S2.62 EPS this Y36.60% Inst Trans-0.29% Short Ratio3.95 Perf Half Y-39.81%
Book/sh-1.46 P/B- EPS next Y26.00% ROA-90.30% Target Price- Perf Year-42.88%
Cash/sh0.71 P/C4.59 EPS next 5Y- ROE136.30% 52W Range3.10 - 9.47 Perf YTD-39.25%
Dividend- P/FCF- EPS past 5Y-14.30% ROI369.80% 52W High-61.66% Beta-
Dividend %- Quick Ratio2.10 Sales past 5Y76.00% Gross Margin75.00% 52W Low17.06% ATR0.22
Employees187 Current Ratio2.20 Sales Q/Q26.10% Oper. Margin-77.90% RSI (14)51.18 Volatility6.57% 6.28%
OptionableYes Debt/Eq- EPS Q/Q16.20% Profit Margin- Rel Volume6.61 Prev Close3.25
ShortableYes LT Debt/Eq- EarningsAug 03 AMC Payout- Avg Volume567.40K Price3.63
Recom1.80 SMA203.09% SMA50-3.55% SMA200-26.58% Volume1,018,888 Change11.66%
Apr-07-21Resumed RBC Capital Mkts Outperform $7
Apr-22-19Initiated H.C. Wainwright Buy
Jan-03-19Initiated Lake Street Buy $14
Aug-20-18Initiated RBC Capital Mkts Outperform $23
Aug-20-18Initiated JMP Securities Mkt Outperform $29
Aug-03-21 07:25PM  
Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates
Zacks
05:55PM  
Aquestive Therapeutics Reports Second Quarter 2021 Financial Results, Provides Business Update and Raises Full Year Revenue Guidance
GlobeNewswire
Jul-27-21 03:02PM  
Earnings Preview: Aquestive Therapeutics (AQST) Q2 Earnings Expected to Decline
Zacks
Jul-21-21 08:00AM  
Aquestive Therapeutics to Report Second Quarter 2021 Financial Results and Recent Business Highlights on August 3 and Host Conference Call on August 4 at 8:00 a.m. ET
GlobeNewswire
Jul-19-21 09:29AM  
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant (diazepam) Buccal Film
GlobeNewswire +7.83%
Jul-05-21 01:55AM  
How Much Did Aquestive Therapeutics'(NASDAQ:AQST) Shareholders Earn From Share Price Movements Over The Last Year?
Simply Wall St.
Jun-24-21 08:00AM  
Aquestive Therapeutics Resubmits New Drug Application for Libervant (diazepam) Buccal Film
GlobeNewswire
Jun-23-21 08:30AM  
SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)
GlobeNewswire +6.99%
Jun-21-21 06:50PM  
Is Aquestive Therapeutics, Inc. (AQST) A Good Stock To Buy?
Insider Monkey
09:15AM  
Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer
GlobeNewswire
Jun-09-21 08:30AM  
Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences
GlobeNewswire
May-11-21 09:27AM  
Aquestive Therapeutics to Participate in 2021 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
May-05-21 06:15AM  
Aquestive Therapeutics, Inc. to Host Earnings Call
ACCESSWIRE +5.48%
May-04-21 08:25PM  
Aquestive Therapeutics (AQST) Reports Q1 Loss, Tops Revenue Estimates
Zacks -8.29%
07:53PM  
Aquestive Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
Apr-30-21 11:37AM  
DEADLINE TODAY: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
11:00AM  
AQST Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Aquestive Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 30, 2021
Business Wire
09:44AM  
AQST Final Deadline Today: Rosen, Trusted National Trial Counsel, Encourages Aquestive Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important April 30 Deadline in Securities Class Action - AQST
Newsfile
12:40AM  
FINAL DEADLINE FRIDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Apr-29-21 02:27PM  
AQST IMPORTANT DEADLINE FRIDAY: ROSEN, A LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important April 30 Deadline in Securities Class Action - AQST
PR Newswire
12:00PM  
FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:33AM  
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
10:14AM  
APRIL 30, 2021 AQST INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Against Aquestive Therapeutics, Inc.
Newsfile
Apr-28-21 10:27PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Newsfile
09:28PM  
Aquestive Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
GlobeNewswire
12:30PM  
APRIL 30 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:33AM  
AQST FINAL DEADLINE ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important April 30 Deadline in Securities Class Action AQST
GlobeNewswire
11:00AM  
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST)
Business Wire
10:45AM  
FRIDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
10:00AM  
AQST Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Aquestive Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 30, 2021
Newsfile
Apr-27-21 10:37AM  
FRIDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
Apr-26-21 11:40PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
PR Newswire
11:00AM  
DEADLINE ALERT for UAVS, IQDAX, IQDNX, and AQST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
11:00AM  
AQST Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Aquestive Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 30, 2021
Business Wire
10:35AM  
FRIDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
Apr-25-21 03:05PM  
Rosen, Top Ranked Global Investor Counsel, Encourages Aquestive Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - AQST
Newsfile
Apr-24-21 01:47AM  
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm
PR Newswire
12:30AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
GlobeNewswire
Apr-23-21 08:02PM  
ROSEN, A LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 30 Deadline in Securities Class Action AQST
GlobeNewswire
01:00PM  
IMPORTANT APRIL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:00AM  
MGI, AQST & VLDR Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
ACCESSWIRE
11:00AM  
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST)
GlobeNewswire
09:00AM  
7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
Apr-22-21 10:15PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Newsfile
Apr-21-21 10:12PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Newsfile +8.67%
02:59PM  
AQST ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Aquestive Therapeutics, Inc. AQST
GlobeNewswire
10:00AM  
MGI, AQST & VLDR Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
GlobeNewswire
09:19AM  
Aquestive Therapeutics to Report First Quarter 2021 Financial Results and Recent Business Highlights on May 4 and Host Conference Call on May 5 at 8:00 a.m. ET
GlobeNewswire
Apr-20-21 11:00AM  
DEADLINE ALERT for UAVS, IQDAX, IQDNX, and AQST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire -5.31%
Apr-19-21 10:09PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
PR Newswire
01:00PM  
DEADLINE ALERT for IQDAX, AQST, VLDR, REGI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
11:00AM  
MGI, AQST & VLDR Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
ACCESSWIRE
Apr-17-21 08:15PM  
AQST INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AQST
PR Newswire
Apr-16-21 11:04PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
ACCESSWIRE
02:30PM  
LOSS ALERT: ROSEN, NATIONAL INVESTOR COUSNEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - AQST
ACCESSWIRE
02:25PM  
ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action - AQST
ACCESSWIRE
11:00AM  
MGI, AQST & VLDR Looming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
ACCESSWIRE
Apr-14-21 11:04PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
GlobeNewswire
04:10PM  
SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:00AM  
MGI, AQST & VLDR Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
ACCESSWIRE
Apr-13-21 11:00AM  
DEADLINE ALERT for UAVS, IQDAX, IQDNX, and AQST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
07:10AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
PR Newswire
Apr-12-21 05:53PM  
Rosen, Leading Trial Attorneys, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST
Newsfile -7.26%
01:00PM  
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST)
GlobeNewswire
01:00PM  
FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
10:00AM  
MGI, AQST & VLDR Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
GlobeNewswire
Apr-10-21 08:12PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Newsfile
05:00PM  
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action AQST
GlobeNewswire
Apr-09-21 01:18PM  
UPCOMING DEADLINE REMINDER: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
PR Newswire
12:00PM  
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors With LARGE LOSSES to Secure Counsel Before Important
ACCESSWIRE
12:00PM  
DEADLINE ALERT for IQDAX, AQST, VLDR, REGI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
Apr-08-21 01:20PM  
SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
10:00AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
ACCESSWIRE
Apr-07-21 02:57PM  
AQST INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Against Aquestive Therapeutics, Inc.
PR Newswire
Apr-06-21 04:34PM  
UPCOMING DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
11:00AM  
MGI, AQST & VLDR Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm
ACCESSWIRE
11:00AM  
DEADLINE ALERT for UAVS, IQDAX, IQDNX, and AQST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
04:30AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
PR Newswire
Apr-04-21 03:47AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
PR Newswire
12:30AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Newsfile
Apr-03-21 12:48PM  
ROSEN, A LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important April 30 Deadline in Securities Class Action AQST
GlobeNewswire
07:00AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
ACCESSWIRE
Apr-02-21 12:15PM  
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Apr-01-21 10:58PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
ACCESSWIRE
07:20PM  
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - AQST
PR Newswire
12:30PM  
DEADLINE ALERT for IQDAX, AQST, VLDR, REGI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
Mar-31-21 02:20PM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE +15.81%
12:28PM  
AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  Aquestive Therapeutics, Inc. AQST
GlobeNewswire
02:54AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
PR Newswire
Mar-30-21 01:00PM  
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST)
GlobeNewswire +7.67%
12:30PM  
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:49AM  
2 Strong Buy Penny Stocks That Could Go Boom
TipRanks
11:00AM  
MGI, AQST & VLDR Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Shareholders to Contact the Firm
ACCESSWIRE
08:00AM  
DEADLINE ALERT for UAVS, IQDAX, IQDNX, and AQST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
Mar-29-21 10:27PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Newsfile
06:19PM  
AQST LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST
Newsfile
01:03PM  
AQST INVESTOR LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Against Aquestive Therapeutics, Inc.
GlobeNewswire
Mar-27-21 09:25PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
ACCESSWIRE
Mar-26-21 05:30PM  
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action AQST
Business Wire
Mar-25-21 12:20PM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
PR Newswire
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schobel Alexander MarkChief Innovation/Tech OfficerFeb 10Sale6.7523,460158,355837,000Feb 10 08:17 PM
Schobel Alexander MarkChief Innovation/Tech OfficerFeb 09Sale6.7511,54077,895860,460Feb 10 08:17 PM
Schobel Alexander MarkChief Innovation/Tech OfficerFeb 08Sale6.5040,792265,148872,000Feb 09 04:00 PM
Maxwell John T.SVP-Chief Financial OfficerAug 18Sale8.003,00024,000150,614Aug 19 08:55 AM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.